Puerarin Inhibits Gastric Cancer Cell Proliferationby Blocking the G2/M Phase Transition

Read full text Summarise with VIRAT
Authors: Jianye Han, Weiwei Yuan
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Gastric cancer is a tumor with high morbidity and mortality with in the world, and according to the statistics of the World Health Organization (WHO), the incidence of gastric cancer is predominant in Asia, especially in East Asia, China and Japan are high-incidence areas, which is related to the special dietary habits of East Asians.Methods: In this study, we first investigated the effects of puerarin on the biological behaviors of two gastric cancer cell lines, HGC27 and AGS. To further explore the underlying mechanisms, we performed transcriptome sequencing, which revealed that puerarin primarily influences gastric cancer progression by regulating cell cycle transitions. To validate these findings, we examined the expression levels of cell cycle-related proteins and analyzed cell cycle distribution using flow cytometry.Results: This study demonstrated that puerarin significantly inhibits the proliferation, migration, and invasion of gastric cancer cells (HGC27 and AGS) while promoting their apoptosis. Transcriptome sequencing analysis revealed that puerarin primarily affects the biological behaviors of gastric cancer cells by regulating the G2-to-M phase transition. To validate this mechanism, we further employed flow cytometry to assess cell cycle distribution and analyzed the expression levels of cell cycle-related proteins, providing protein-level evidence that supports the G2/M phase transition regulation identified in the transcriptomic data.Conclusion: Puerarin effectively inhibits the proliferation and invasion of gastric cancer cells. Its mechanism is closely related to the regulation of the G2-to-M phase transition, thereby affecting cell cycle progression and proliferative capacity.

Fields of Study & Subjects

Cancer-related Molecular Pathways Flavonoids in Medical Research Natural Compounds in Disease Treatment

Publication details

Journal / source
Life Conflux
Volume
2
Issue
2
Pages
e301–e301
Publication date
10 February 2026
Language
EN